|
|
Welcome to the Vaccines for Respiratory Illnesses Newsletter (Previously COVID-19 and Other Respiratory Illness Vaccines: A Partner Newsletter). Here you'll find the latest news and information on respiratory illness vaccine related topics.
|
|
August is National Immunization Awareness Month (NIAM), an annual observance that highlights the importance of vaccination for people of all ages. National partners have created materials and resources you can use to promote immunization on social media and beyond. Here's how you can get involved:
|
|
A: Aim for nirsevimab administration in the first week of life for infants born shortly before or during the RSV season (typically October through March). Infants with prolonged birth hospitalizations due to prematurity or other causes should receive nirsevimab shortly before or promptly after discharge.
Infants younger than age 8 months born outside of the RSV season and older infants or toddlers at high risk who are recommended to receive nirsevimab in their second RSV season, should aim to receive nirsevimab shortly before the start of the RSV season (typically October). If the ideal timing is missed, age-eligible infants and children who have not yet received a dose may be immunized at any time during the RSV season.
This week, our question is from a featured episode from the Ask the Experts Video Series.
|
|
|
The Association of Immunization Managers (AIM) has developed a new toolkit. This toolkit includes resources that provide answers to the “what,” “why,” and “how” of implementing five promising practices for improving pediatric COVID-19 immunization rates. It also includes examples from the field, partnerships to consider, resources, tools, tips, and lessons learned. We invite you to share these resources with your networks, and we would appreciate any opportunities to amplify these tools through newsletters, webinars, podcasts, and other avenues.
Additionally, AIM is hosting a webinar on August 9 from 2 - 3 pm ET to share more about the toolkit and actionable steps and considerations for replicating the five promising practices across jurisdictions after the COVID-19 public health emergency. Register for the webinar here.
|
|
|
Back in June 2024, The Advisory Committee on Immunization Practices voted on the following recommendations:
- Routine, one-time RSV vaccination of all previously unvaccinated adults age 75 years and older, and vaccination of adults age 60–74 years with specific risk conditions only
- Use of 21-valent pneumococcal conjugate vaccine (PCV21) as a product option for adults already recommended to receive PCV
- Use of 2024–25 season influenza vaccines in all people age 6 months and older, and addition of high-dose and adjuvanted vaccine options for immunocompromised adults younger than age 65 years
- Use of 2024–25 season COVID-19 vaccines in all people age 6 months and older
- Addition of DTaP-IPV-Hib-HepB (Vaxelis, Merck/Sanofi, MSP) as a preferred product option for vaccination of American Indian and Alaska Native infants
You can find a full copy of what was presented at this meeting at the following link: ACIP June 26-28, 2024 Presentation Slides | Immunization Practices | CDC.
|
|
|
To help vaccine providers prepare for this fall and winter virus season, CDC is sharing information on immunizations for three common causes of respiratory illness: flu, COVID-19, and respiratory syncytial virus (RSV). The CDC launched new webpages with detailed COVID-19 and RSV product summaries to inform vaccine ordering for the fall/winter respiratory virus season.
|
|
|
Immunize.org released a new document that now puts every injectable influenza vaccine VIS translation at your fingertips as you prepare for influenza vaccination clinics this fall. Titled QR Code Links to Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant), this 3-page PDF assembles QR codes for 44 injectable influenza VIS translations.
Page one leads off with basic instructions, along with the QR code to the required English VIS and the most popular Spanish VIS. Pages two and three provide the QR codes for each additional language option, along with a few additional VIS resources for healthcare professionals. Beneath each QR code is the language (in English) and the VIS title in each language. This allows vaccine recipients who do not read English to locate and scan the code for their preferred language with their own smartphone.
This resource is durable. If an English or translated VIS is updated, the QR code will automatically link to the current available version online at Immunize.org. Download this resource today as you prepare for influenza vaccination clinics this fall.
|
|
|
The Washington State Department of Health (DOH) is hosting a webinar at 12pm PT on Thursday, August 29, 2024. Department of Health staff will discuss current COVID-19 vaccine recommendations, vaccine ordering, and storage and handling guidelines. DOH will record the webinar for future viewing. Continuing education is available for nurses and medical assistants.
Learning Objectives:
- Understand the COVID-19 vaccine recommendations for 2024-2025.
- Describe vaccine ordering and availability through DOH's Childhood and Adult Vaccine Programs.
- Discuss current COVID-19 vaccine storage and handling guidelines.
Visit our webinar web page for more details, or check out our immunization training page for more education opportunities.
We look forward to seeing you there!
Join AAP and CDC experts for a webinar on Tuesday, August 27 at 11 am CT to hear the latest about immunizations, treatment, and other tools to protect pediatric patients from respiratory viruses during the 24-25 fall and winter respiratory virus season. CDC presenters will review data and outline current recommendations for prevention of influenza, COVID-19, and respiratory syncytial virus (RSV), which will be followed by a facilitated question and answer session. Continuing Education credits will be available for a variety of professions.
|
|
|
|
FOR SCHOOLS AND CHILD CARE FACILITIES
FOR LONG-TERM CARE FACILITIES
|
|
|
|
|
|
|
If you aren't already signed up for Vaccines for Respiratory Illnesses Newsletter, please visit the Department of Health's email subscribers page here. Once you enter your email, on the next page expand the Immunization topic, select the COVID-19 Vaccine Partner Newsletter (our original title), and click submit.
|
|
This newsletter summarizes content beginning the week of August 5, 2024 and was sent out on August 9, 2024. |
|
|
|
|
